Skip to main content
E2

EUROPHARMA.DK 2012 ApS UNDER STIFTELSE

inaktiv
CVR 34601933Anpartsselskab
Latest accounts
2016
Statement scope
Standalone
Verified
17 Nov 2026
Sources
5

What changed?

Source-backed changes, not an assessment.

2016
Source note

Source access required

CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.

1 source

Key figures

Latest period: 2016

Revenue

Data quality concern

—

Data quality concern

Operating profit

DKK 9.6m

Latest period

Source details

Source: dk-regnskabsdata-live-34601933-1794958558626

Document: dk-regnskabsdata-34601933-X17-AL-81-KV-1

XBRL: e:ProfitLossFromOrdinaryOperatingActivities

Period: 01 Jan 2016 - 31 Dec 2016

Technical details

Context: c1

Unit: u5

Net result

DKK 6.5m

Latest period

Source details

Source: dk-regnskabsdata-live-34601933-1794958558626

Document: dk-regnskabsdata-34601933-X17-AL-81-KV-1

XBRL: e:ProfitLoss

Period: 01 Jan 2016 - 31 Dec 2016

Technical details

Context: c1

Unit: u5

Equity

DKK 80.6m

Equity ratio: 42%

Source details

Source: dk-regnskabsdata-live-34601933-1794958558626

Document: dk-regnskabsdata-34601933-X17-AL-81-KV-1

XBRL: e:Equity

Period: 01 Jan 2016 - 31 Dec 2016

Technical details

Context: c6

Unit: u5

Development

Reported values. Missing periods appear as gaps.

Open full financials
RevenueNet result
Tabular view of development
YearRevenueNet result
2013—DKK -12.5m
2014—DKK 2.8m
2015—DKK 311.7k
2016—DKK 6.5m